238 related articles for article (PubMed ID: 24094113)
1. MiR-34a is up-regulated in response to low dose, low energy X-ray induced DNA damage in breast cells.
Stankevicins L; Almeida da Silva AP; Ventura Dos Passos F; Dos Santos Ferreira E; Menks Ribeiro MC; G David M; J Pires E; Ferreira-Machado SC; Vassetzky Y; de Almeida CE; de Moura Gallo CV
Radiat Oncol; 2013 Oct; 8():231. PubMed ID: 24094113
[TBL] [Abstract][Full Text] [Related]
2. miR-155, miR-21, and let-7a Expressions in MCF-10A and MCF-7 Cell Lines after Low to High Dose Irradiation.
Zare A; Fardid R; Tamadon GHH; Mosleh-Shirazi MA
Cell J; 2021 Oct; 23(5):532-537. PubMed ID: 34837680
[TBL] [Abstract][Full Text] [Related]
3. Expression level of miR-34a rather than P53 gene status correlates with mutability in related human lymphoblast cell lines.
Chen X; Yan J; Chen T
Mol Carcinog; 2012 Aug; 51(8):674-7. PubMed ID: 21809390
[TBL] [Abstract][Full Text] [Related]
4. miR-34a as part of the resistance network in chronic lymphocytic leukemia.
Zenz T; Mohr J; Eldering E; Kater AP; Bühler A; Kienle D; Winkler D; Dürig J; van Oers MH; Mertens D; Döhner H; Stilgenbauer S
Blood; 2009 Apr; 113(16):3801-8. PubMed ID: 18941118
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic effects of valproic acid on miR-34a, miR-520h and HDAC1 gene in breast cancer.
Injinari N; Amini-Farsani Z; Yadollahi-Farsani M; Teimori H
Life Sci; 2021 Mar; 269():119027. PubMed ID: 33453248
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis.
Javeri A; Ghaffarpour M; Taha MF; Houshmand M
Med Oncol; 2013 Mar; 30(1):413. PubMed ID: 23292869
[TBL] [Abstract][Full Text] [Related]
7. MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.
Si W; Li Y; Shao H; Hu R; Wang W; Zhang K; Yang Q
Am J Med Sci; 2016 Aug; 352(2):191-9. PubMed ID: 27524218
[TBL] [Abstract][Full Text] [Related]
8. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol.
Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T
Adv Clin Exp Med; 2018 Jul; 27(7):941-945. PubMed ID: 30019863
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of miR-34a Effect on CCND1 mRNA Level and Sensitization of Breast Cancer Cell Lines to Paclitaxel.
Irani S; Paknejad M; Soleimani M; Azam S
Iran Biomed J; 2020 Nov; 24(6):361-9. PubMed ID: 32660221
[TBL] [Abstract][Full Text] [Related]
10. Could miR-34a Inhibition be Used as a Tool to Overcome Drug Resistance in MCF-7 Cells Treated with Synthesized Steroidal Heterocycles?
Yahya SMM; Abd-Elhalim MM; Abdelhamid AO; Eskander EF; Elsayed GH
Asian Pac J Cancer Prev; 2021 Mar; 22(3):819-826. PubMed ID: 33773546
[TBL] [Abstract][Full Text] [Related]
11. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
12. [miR-34a may regulate sensitivity of breast cancer cells to adriamycin via targeting Notch1].
Li X; Zhao J; Tang J
Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):892-6. PubMed ID: 25623761
[TBL] [Abstract][Full Text] [Related]
13. Phytochemical regulation of the tumor suppressive microRNA, miR-34a, by p53-dependent and independent responses in human breast cancer cells.
Hargraves KG; He L; Firestone GL
Mol Carcinog; 2016 May; 55(5):486-98. PubMed ID: 25789847
[TBL] [Abstract][Full Text] [Related]
14. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
[TBL] [Abstract][Full Text] [Related]
15. Micro RNA 34a and Let-7a Expression in Human Breast Cancers is Associated with Apoptotic Expression Genes.
Mansoori B; Mohammadi A; Shirjang S; Baghbani E; Baradaran B
Asian Pac J Cancer Prev; 2016; 17(4):1887-90. PubMed ID: 27221871
[TBL] [Abstract][Full Text] [Related]
16. Biological effects induced by doses of mammographic screening.
Pereira L; Ferreira MT; Lima AGF; Salata C; Ferreira-Machado SC; Lima I; Morandi V; Magalhães LAG
Phys Med; 2021 Jul; 87():90-98. PubMed ID: 34130221
[TBL] [Abstract][Full Text] [Related]
17. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
18. The secretome of non-tumorigenic mammary cells MCF-10A elicits DNA damage in MCF-7 and MDA-MB-231 breast cancer cells.
Vedoya GM; López Nigro MM; Martín GA
Toxicol In Vitro; 2021 Feb; 70():105018. PubMed ID: 33049311
[TBL] [Abstract][Full Text] [Related]
19. Radiation resistance due to high expression of miR-21 and G2/M checkpoint arrest in breast cancer cells.
Anastasov N; Höfig I; Vasconcellos IG; Rappl K; Braselmann H; Ludyga N; Auer G; Aubele M; Atkinson MJ
Radiat Oncol; 2012 Dec; 7():206. PubMed ID: 23216894
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-34a induces a senescence-like change via the down-regulation of SIRT1 and up-regulation of p53 protein in human esophageal squamous cancer cells with a wild-type p53 gene background.
Ye Z; Fang J; Dai S; Wang Y; Fu Z; Feng W; Wei Q; Huang P
Cancer Lett; 2016 Jan; 370(2):216-21. PubMed ID: 26523671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
